Baxter Receivables 2010-2025 | BAX
Baxter receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
- Baxter receivables for the quarter ending June 30, 2025 were $1.773B, a 32.82% decline year-over-year.
- Baxter receivables for 2024 were $1.679B, a 2.33% decline from 2023.
- Baxter receivables for 2023 were $1.719B, a 33.14% decline from 2022.
- Baxter receivables for 2022 were $2.571B, a 2.21% decline from 2021.
| Baxter Annual Receivables (Millions of US $) |
|
|---|---|
| 2024 | $1,679 |
| 2023 | $1,719 |
| 2022 | $2,571 |
| 2021 | $2,629 |
| 2020 | $2,007 |
| 2019 | $1,896 |
| 2018 | $1,840 |
| 2017 | $1,793 |
| 2016 | $1,691 |
| 2015 | $1,731 |
| 2014 | $1,884 |
| 2013 | $2,911 |
| 2012 | $2,425 |
| 2011 | $2,420 |
| 2010 | $2,265 |
| 2009 | $2,302 |
| Baxter Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,773 |
| 2025-03-31 | $1,646 |
| 2024-12-31 | $1,679 |
| 2024-09-30 | $1,729 |
| 2024-06-30 | $2,639 |
| 2024-03-31 | $2,521 |
| 2023-12-31 | $1,719 |
| 2023-09-30 | $2,512 |
| 2023-06-30 | $2,495 |
| 2023-03-31 | $2,547 |
| 2022-12-31 | $2,571 |
| 2022-09-30 | $2,555 |
| 2022-06-30 | $2,473 |
| 2022-03-31 | $2,471 |
| 2021-12-31 | $2,629 |
| 2021-09-30 | $2,074 |
| 2021-06-30 | $2,021 |
| 2021-03-31 | $1,915 |
| 2020-12-31 | $2,007 |
| 2020-09-30 | $2,001 |
| 2020-06-30 | $1,884 |
| 2020-03-31 | $1,892 |
| 2019-12-31 | $1,896 |
| 2019-09-30 | $1,814 |
| 2019-06-30 | $1,885 |
| 2019-03-31 | $1,802 |
| 2018-12-31 | $1,840 |
| 2018-09-30 | $1,826 |
| 2018-06-30 | $1,783 |
| 2018-03-31 | $1,807 |
| 2017-12-31 | $1,793 |
| 2017-09-30 | $1,748 |
| 2017-06-30 | $1,721 |
| 2017-03-31 | $1,646 |
| 2016-12-31 | $1,691 |
| 2016-09-30 | $1,739 |
| 2016-06-30 | $1,813 |
| 2016-03-31 | $1,830 |
| 2015-12-31 | $1,731 |
| 2015-09-30 | $1,772 |
| 2015-06-30 | $2,852 |
| 2015-03-31 | $2,599 |
| 2014-12-31 | $1,884 |
| 2014-09-30 | $2,842 |
| 2014-06-30 | $2,914 |
| 2014-03-31 | $2,708 |
| 2013-12-31 | $2,911 |
| 2013-09-30 | $2,766 |
| 2013-06-30 | $2,342 |
| 2013-03-31 | $2,319 |
| 2012-12-31 | $2,425 |
| 2012-09-30 | $2,324 |
| 2012-06-30 | $2,225 |
| 2012-03-31 | $2,341 |
| 2011-12-31 | $2,420 |
| 2011-09-30 | $2,347 |
| 2011-06-30 | $2,491 |
| 2011-03-31 | $2,399 |
| 2010-12-31 | $2,265 |
| 2010-09-30 | $2,205 |
| 2010-06-30 | $2,072 |
| 2010-03-31 | $2,254 |
| 2009-12-31 | $2,302 |
| 2009-09-30 | $2,229 |
| 2009-06-30 | $2,133 |
| 2009-03-31 | $1,940 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.558B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.007B | 26.38 |
| Boston Scientific (BSX) | United States | $154.324B | 36.80 |
| Stryker (SYK) | United States | $144.711B | 29.46 |
| EssilorLuxottica (ESLOY) | France | $142.399B | 0.00 |
| Medtronic (MDT) | Ireland | $117.900B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.114B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.571B | 24.87 |
| ResMed (RMD) | United States | $41.687B | 29.81 |
| Agilent Technologies (A) | United States | $33.767B | 22.01 |
| GE HealthCare Technologies (GEHC) | United States | $33.630B | 15.81 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $26.220B | 17.34 |
| Insulet (PODD) | United States | $22.229B | 74.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.230B | 12.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.773B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.704B | 10.01 |
| Envista Holdings (NVST) | United States | $3.460B | 24.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.179B | 14.10 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $2.762B | 18.81 |
| Haemonetics (HAE) | United States | $2.521B | 11.25 |
| LeMaitre Vascular (LMAT) | United States | $2.169B | 46.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.969B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.827B | 78.46 |
| QuidelOrtho (QDEL) | United States | $1.762B | 11.09 |
| AtriCure (ATRC) | United States | $1.760B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.299B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.84 |
| BioLife Solutions (BLFS) | United States | $1.213B | 2532.00 |
| Neogen (NEOG) | United States | $1.195B | 18.97 |
| Acuren (TIC) | United States | $1.153B | 0.00 |
| InMode (INMD) | Israel | $0.903B | 8.35 |
| Valneva SE (VALN) | France | $0.891B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.820B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| SNDL (SNDL) | Canada | $0.554B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.543B | 0.00 |
| Surmodics (SRDX) | United States | $0.538B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| Cresco Labs (CRLBF) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.447B | 15.40 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.417B | 3.70 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.357B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.356B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Omeros (OMER) | United States | $0.254B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 49.35 |
| Vireo Growth (VREOF) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.209B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 15.21 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.67 |
| Biote (BTMD) | United States | $0.147B | 4.89 |
| TriSalus Life Sciences (TLSI) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.14 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.080B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 35.37 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Veru (VERU) | United States | $0.054B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 33.33 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |